Complete Filing Data
EUDA Health Holdings Ltd reported Net Income Loss of -$15.36 million for FY2024.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean EUDA Health Holdings Ltd did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|
| Net Income * | -$15.4M | -$10.0M | -$24.9M | $864.8K |
| Operating Income Loss | -$17.3M | -$4.0M | -$12.2M | -$560.0K |
| Nonoperating Income Expense | -$307.0K | -$4.5M | -$12.8M | $2.2M |
| Revenue From Contract With Customer Excluding Assessed Tax | $4.0M | $3.7M | $3.8M | $4.6M |
| Selling And Marketing Expense | $129.9K | $533.6K | $935.6K | $333.7K |
| Other Nonoperating Income Expense | $185.9K | $134.6K | $195.8K | $313.9K |
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | -$75.4K | -$60.0K | -$131.9K | $17.0K |
| Operating Expenses | $18.1M | $4.8M | $13.1M | $1.8M |
| Net Income Loss Attributable To Noncontrolling Interest | -$34.3K | $3.4K | -$65.1K | $35.6K |
| Income Taxes Paid Net | $11.6K | $42.9K | $156.3K | $30.2K |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$17.6M | -$8.4M | -$25.0M | $1.7M |
| Gross Profit | $762.2K | $842.1K | $870.0K | $1.2M |
| General And Administrative Expense | $3.2M | $4.3M | $5.8M | $1.5M |
| Cost Of Revenue | $3.2M | $2.9M | $2.9M | $3.3M |
| Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest | -$15.5M | -$10.1M | -$25.1M | $917.4K |
| Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest | -$35.6K | $3.1K | -$65.3K | $35.6K |
| Comprehensive Income Net Of Tax | -$15.4M | -$10.1M | -$25.0M | $881.8K |
| Interest Expense Other | $44.9K | $23.2K | $93.8K | $1.6K |
| Income Tax Expense Benefit | -$4.4K | -$20.8K | $46.5K | |
| Deferred Income Tax Expense Benefit | -$4.4K | -$48.2K | -$27.7K | |
| Amortization Of Intangible Assets | $20.2K | $115.9K | $162.8K | |
| Income Loss From Continuing Operations Per Diluted Share | -$0.54 | -$0.37 | -$2.07 | $0.17 |
| Income Loss From Continuing Operations Per Basic Share | -$0.54 | -$0.37 | -$2.07 | $0.17 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2023 | Q4 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|---|---|---|
| Net Income * | -$2.4M | $201.0K | -$473.0K | $222.6K | -$45.6K | -$6.7K | -$1.2K |
| Operating Income Loss | -$2.0M | -$298.3K | -$481.6K | $75.3K | -$45.6K | -$6.7K | -$1.2K |
| Nonoperating Income Expense | -$435.5K | $499.3K | $8.6K | $155.5K | |||
| Revenue From Contract With Customer Excluding Assessed Tax | $1.7M | $2.7M | |||||
| Selling And Marketing Expense | $404.8K | $368.1K | |||||
| Other Nonoperating Income Expense | $108.4K | $145.5K | |||||
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | -$18.3K | -$4.0K | |||||
| Operating Expenses | $2.4M | $1.2M | |||||
| Net Income Loss Attributable To Noncontrolling Interest | $1.4K | $2.4K | |||||
| Income Taxes Paid Net | $9.4K | $33.3K | |||||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$2.4M | $230.8K | |||||
| Gross Profit | $403.6K | $1.3M | |||||
| General And Administrative Expense | $2.0M | $824.9K | |||||
| Cost Of Revenue | $1.3M | $1.4M | |||||
| Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest | -$2.4M | $221.0K | |||||
| Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest | $1.5K | $2.2K | |||||
| Comprehensive Income Net Of Tax | -$2.4M | $218.8K | |||||
| Interest Expense Other | $11.4K | $20.1K | |||||
| Income Tax Expense Benefit | $985.00 | $5.8K | |||||
| Deferred Income Tax Expense Benefit | -$5.0K | ||||||
| Amortization Of Intangible Assets | $29.5K | ||||||
| Income Loss From Continuing Operations Per Diluted Share | |||||||
| Income Loss From Continuing Operations Per Basic Share |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Stockholders Equity * | -$2.6M | -$7.5M | -$3.5M | $521.2K | -$317.4K |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $237.6K | $197.6K | $784.5K | $190.0K | $250.8K |
| Retained Earnings Accumulated Deficit | -$50.1M | -$34.7M | -$24.7M | $180.3K | |
| Liabilities And Stockholders Equity | $1.7M | $1.3M | $25.6M | $8.0M | |
| Assets | $1.7M | $1.3M | $25.6M | $8.0M | |
| Assets Current | $762.9K | $723.4K | $25.0M | $4.4M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $40.1K | -$586.9K | $594.5K | -$60.8K | |
| Liabilities | $4.3M | $8.8M | $29.1M | $7.4M | |
| Liabilities Current | $4.1M | $8.7M | $29.1M | $7.3M | |
| Cash And Cash Equivalents At Carrying Value | $189.0K | $57.5K | $190.0K | ||
| Operating Lease Right Of Use Asset Amortization Expense | $125.5K | $106.3K | $42.7K | $58.6K | |
| Initial Recognition Of Operating Right Of Use Asset And Lease Liability | $159.4K | $236.7K | $105.4K | $125.8K | |
| Finance Lease Right Of Use Asset Amortization | $5.5K | $8.1K | $7.9K | $8.2K | |
| Finance Lease Principal Payments | $4.5K | $5.9K | $6.5K | $6.7K | |
| Common Stock No Par Value | $0.00 | ||||
| Accounts Receivable Net Current | $146.2K | $237.5K | $192.9K | $1.8M | |
| Taxes Payable Current | $263.0K | $208.7K | $117.5K | $307.3K | |
| Property Plant And Equipment Net | $87.7K | $6.7K | $11.5K | $56.9K | |
| Prepaid Expense And Other Assets Current | $226.0K | $192.4K | $155.4K | $71.5K | |
| Other Payables And Accrued Liabilities | $1.6M | $1.9M | $1.2M | $488.6K | |
| Other Assets | $847.2K | $580.3K | $570.9K | $3.6M | |
| Operating Lease Right Of Use Asset | $203.0K | $168.3K | $36.5K | $79.9K | |
| Operating Lease Liability Current | $174.8K | $121.8K | $36.5K | $63.5K | |
| Minority Interest | -$19.0K | $16.6K | $13.5K | $78.8K | |
| Liabilities Noncurrent | $128.5K | $75.1K | $15.0K | $82.9K | |
| Finance Lease Right Of Use Asset | $25.6K | $32.0K | $16.3K | $24.4K | |
| Finance Lease Liability Noncurrent | $23.6K | $28.6K | $15.0K | $17.3K | |
| Finance Lease Liability Current | $4.6K | $5.1K | $7.2K | $11.4K | |
| Common Stock Value | $47.8M | $27.4M | $21.3M | $334.9K | |
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$259.5K | -$185.5K | -$125.7K | $6.0K | |
| Accounts Payable Current | $25.9K | $1.3K | $359.7K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | -$6.0M | -$4.0M | -$3.7M | -$2.5M | -$2.0M | -$16.5K | $29.1K | $17.2K | -$1.2K |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $837.3K | $265.9K | $193.5K | $546.9K | $237.2K | ||||
| Retained Earnings Accumulated Deficit | -$27.1M | -$4.0M | -$3.7M | -$2.5M | -$2.0M | -$54.0K | |||
| Liabilities And Stockholders Equity | $25.5M | $87.3M | $86.8M | $86.9M | $87.0M | $490.2K | |||
| Assets | $25.5M | $87.3M | $86.8M | $86.9M | $87.0M | $490.2K | |||
| Assets Current | $24.8M | $87.3M | $86.8M | $86.9M | $87.0M | ||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $52.8K | $72.3K | $47.3K | ||||||
| Liabilities | $31.4M | $5.0M | $4.7M | $3.9M | $3.4M | $506.6K | |||
| Liabilities Current | $31.3M | $506.6K | $399.8K | ||||||
| Cash And Cash Equivalents At Carrying Value | $837.3K | $265.9K | $193.5K | $546.9K | $587.4K | ||||
| Operating Lease Right Of Use Asset Amortization Expense | $36.4K | $15.5K | |||||||
| Initial Recognition Of Operating Right Of Use Asset And Lease Liability | $139.5K | $125.8K | |||||||
| Finance Lease Right Of Use Asset Amortization | $2.1K | $2.0K | |||||||
| Finance Lease Principal Payments | $1.7K | $1.6K | |||||||
| Common Stock No Par Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||
| Accounts Receivable Net Current | $1.6M | ||||||||
| Taxes Payable Current | $219.6K | ||||||||
| Property Plant And Equipment Net | $27.9K | ||||||||
| Prepaid Expense And Other Assets Current | $198.1K | ||||||||
| Other Payables And Accrued Liabilities | $2.5M | ||||||||
| Other Assets | $648.8K | ||||||||
| Operating Lease Right Of Use Asset | $180.5K | ||||||||
| Operating Lease Liability Current | $108.9K | ||||||||
| Minority Interest | $15.0K | ||||||||
| Liabilities Noncurrent | $85.0K | ||||||||
| Finance Lease Right Of Use Asset | $14.4K | ||||||||
| Finance Lease Liability Noncurrent | $13.3K | ||||||||
| Finance Lease Liability Current | $7.3K | ||||||||
| Common Stock Value | $21.3M | ||||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$144.1K | ||||||||
| Accounts Payable Current | $1.8M | $1.6M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|
| Financing Cash Flow * | $2.3M | $2.4M | $2.5M | -$168.4K |
| Investing Cash Flow * | -$147.8K | -$268.2K | -$356.2K | |
| Operating Cash Flow * | -$2.0M | -$2.9M | -$1.5M | $443.9K |
| Increase Decrease In Prepaid Expense | -$69.3K | -$61.6K | -$21.9K | $12.8K |
| Proceeds From Related Party Debt | $208.9K | $1.4M | $244.0K | |
| Increase Decrease In Other Receivables | -$210.00 | -$1.0K | -$1.6M | -$5.8K |
| Increase Decrease In Other Accounts Payable And Accrued Liabilities | -$235.2K | $519.7K | $1.1M | -$142.9K |
| Increase Decrease In Operating Lease Liability | -$125.5K | -$106.3K | -$42.7K | -$62.1K |
| Increase Decrease In Accrued Income Taxes Payable | $62.9K | $87.9K | -$37.6K | $6.0K |
| Increase Decrease In Accounts Receivable | -$85.2K | $34.0K | -$142.0K | $92.9K |
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | -$101.7K | -$21.5K | -$99.4K | $19.9K |
| Increase Decrease In Accounts Payable | $16.0K | $1.3K | $1.3M | $353.6K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2023 | Q4 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|
| Financing Cash Flow * | $525.3K | $196.1K | $331.4K | |
| Investing Cash Flow * | -$29.3K | |||
| Operating Cash Flow * | -$469.9K | -$123.8K | -$252.2K | |
| Increase Decrease In Prepaid Expense | -$49.6K | -$78.5K | $12.8K | -$45.5K |
| Proceeds From Related Party Debt | $138.2K | $196.1K | $269.5K | |
| Increase Decrease In Other Receivables | $3.3K | $15.5K | ||
| Increase Decrease In Other Accounts Payable And Accrued Liabilities | $870.0K | $7.3K | ||
| Increase Decrease In Operating Lease Liability | -$39.7K | -$15.5K | ||
| Increase Decrease In Accrued Income Taxes Payable | $31.9K | $93.00 | ||
| Increase Decrease In Accounts Receivable | -$244.7K | $264.6K | ||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | -$2.6K | -$2.7K | ||
| Increase Decrease In Accounts Payable | $187.4K | -$2.3K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|
| Diluted EPS * | -$0.47 | -$0.44 | -$2.07 | $0.09 |
| Common Stock Shares Outstanding | 37.2M | 24.6M | 20.2M | 9.3M |
| Weighted Average Number Of Shares Outstanding Basic | 32.5M | 22.9M | 12.0M | 9.3M |
| Earnings Per Share Basic | $-0.47 | $-0.44 | $-2.07 | $0.09 |
| Weighted Average Number Of Diluted Shares Outstanding | 32.5M | 22.9M | 12.0M | 9.3M |
| Common Stock Shares Issued | 2.2M | |||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.12 | $0.02 | -$0.02 | |||
| Common Stock Shares Outstanding | 20.2M | 2.4M | 2.4M | 2.4M | 2.4M | 2.2M |
| Weighted Average Number Of Shares Outstanding Basic | 20.2M | 9.3M | ||||
| Earnings Per Share Basic | $-0.12 | $0.02 | ||||
| Weighted Average Number Of Diluted Shares Outstanding | 20.2M | 9.3M | ||||
| Common Stock Shares Issued | 2.4M | 2.4M | 2.4M | 2.4M | ||
| Common Stock Par Or Stated Value Per Share | $0.00 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|
| Stock Issued During Period Value New Issues | $500.0K | $25.0K | ||
| Stock Issued During Period Shares New Issues | 1.4M | 1.0M | 6.2M | |
| Interest Paid Net | $55.4K | $17.5K | $19.6K | $110.8K |
| Depreciation | $22.1K | $4.9K | $5.5K | $5.0K |
| Prepaid Expense Current | $181.0K | |||
| Prepaid Expense Noncurrent | $281.4K | $380.1K | $478.1K | |
| Operating Costs And Expenses | $2.0M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|---|---|---|---|---|
| Stock Issued During Period Value New Issues | $86.3M | ||||||||
| Stock Issued During Period Shares New Issues | 1.4M | ||||||||
| Interest Paid Net | $6.1K | $24.3K | |||||||
| Depreciation | $4.0K | $7.0K | |||||||
| Prepaid Expense Current | $30.6K | $109.1K | $137.9K | $140.5K | $135.5K | ||||
| Prepaid Expense Noncurrent | $453.9K | ||||||||
| Operating Costs And Expenses | $298.3K | $481.6K | $225.6K | $45.6K | $6.7K | $1.2K |
Most recent annual filing with the SEC: April 29, 2025
Data sourced from SEC EDGAR public filings as of August 6, 2026.